Cargando…
Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407481/ https://www.ncbi.nlm.nih.gov/pubmed/37559602 http://dx.doi.org/10.21037/jtd-23-598 |
| _version_ | 1785085972381171712 |
|---|---|
| author | Cagney, Hannah P. Petty, Russell D. Baxter, Mark A. |
| author_facet | Cagney, Hannah P. Petty, Russell D. Baxter, Mark A. |
| author_sort | Cagney, Hannah P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10407481 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104074812023-08-09 Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management? Cagney, Hannah P. Petty, Russell D. Baxter, Mark A. J Thorac Dis Editorial AME Publishing Company 2023-06-20 2023-07-31 /pmc/articles/PMC10407481/ /pubmed/37559602 http://dx.doi.org/10.21037/jtd-23-598 Text en 2023 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Cagney, Hannah P. Petty, Russell D. Baxter, Mark A. Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management? |
| title | Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management? |
| title_full | Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management? |
| title_fullStr | Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management? |
| title_full_unstemmed | Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management? |
| title_short | Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management? |
| title_sort | immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407481/ https://www.ncbi.nlm.nih.gov/pubmed/37559602 http://dx.doi.org/10.21037/jtd-23-598 |
| work_keys_str_mv | AT cagneyhannahp immunecheckpointinhibitioninadvancedesophagealsquamouscellcarcinomahowcanwepersonalisemanagement AT pettyrusselld immunecheckpointinhibitioninadvancedesophagealsquamouscellcarcinomahowcanwepersonalisemanagement AT baxtermarka immunecheckpointinhibitioninadvancedesophagealsquamouscellcarcinomahowcanwepersonalisemanagement |